Jenn Holloway, Author at ISR Market Research

Benefits and Drawbacks of Clinical Development Outsourcing Strategies

By Jenn HollowayClinical Trials

Perspectives on Clinical Development Outsourcing Outsourcing plays a vital role in the clinical development programs of biopharmaceutical companies, offering increased flexibility; access to external expertise and technological advancements; and improved efficiency. Our research on clinical development outsourcing models provides valuable...

Tracking the Evolution of CDMO Selection Criteria for Biologic Drug Substance Manufacturing

By Jenn HollowayManufacturing

Biologic drug substance developers face an ever-evolving slate of challenges related to CDMO outsourcing. As part of ISR’s CDMO Benchmarking research, respondents are asked to review a list of 28 selection attributes and to identify the one criterion most important...